Korean aesthetic device company reported on Wednesday the receipt of the US Food and Drug Administration's 510 (K) clearance to market WONTECH SANDRO DUAL laser device across the global markets, including the US and Europe.
Recently, the SANDRO DUAL was launched in Korea Nd:YAG & Alexandrite based lasers mounted on one device.
According to the company, the SANDRO DUAL can be implemented in the hybrid mode in a short time difference between two wavelengths of 755nm and 1064nm. The energy is accurately delivered to a specific area to deliver an effective and quick treatment in hair removal as well as whitening without damaging surrounding tissue.
In addition, the the SANDRO DUAL's SCS (Skin Cooling Spray) cooling system minimizes patient discomfort from pain, swelling and redness.
Renalytix advances kidneyintelX.Dkd scale-up with laboratory expansion and CE submission
FDA extends review timeline for Sanofi's Sarclisa subcutaneous formulation in multiple myeloma
FDA expands approval of Sanofi's Tzield for early-stage type 1 diabetes in young children
Inhibrx provides clinical update on ozekibart (INBRX-109) for colorectal cancer treatment
LENZ Therapeutics advances VIZZ regulatory expansion with UK submission for presbyopia treatment
Lundbeck presents new real-world data on VYEPTI (eptinezumab) at AAN 2026
European Commission approves Merck's ENFLONSIA for infant RSV prevention in Europe
Cumberland Pharmaceuticals secures FDA approval for expanded Caldolor indication
Philips secures FDA clearance for Spectral CT Verida system
Adimab partner GSK receives additional marketing approvals for depemokimab